Economic Evaluation of New MDR TB Regimens (PRACTECAL-EE)
Economic Evaluation of New MDR TB Regimens (PRACTECAL EE)
Sponsor: London School of Hygiene and Tropical Medicine
Listed as NCT04207112, this PHASE2/PHASE3 trial focuses on Extensively Drug-Resistant Tuberculosis and Multi-drug Resistant Tuberculosis and remains completed. Sponsored by London School of Hygiene and Tropical Medicine, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
May 2024 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Status: Unknown Status → Completed
-
Jun 2023 — May 2024 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
-
Jun 2021 — Jun 2023 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jan 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- London School of Hygiene and Tropical Medicine
- Medecins Sans Frontieres, Netherlands
- Ministry of Health, Republic of Uzbekistan
- Ministry of Public Health, Republic of Belarus
- THINK TB & HIV Investigative Network
- University of Liverpool
- Wits Health Consortium (Pty) Ltd
For direct contact, visit the study record on ClinicalTrials.gov .